CTSI Alerts! test notifications went out Jan. 27th at 2 PM. Learn more here.

2023 Community Meetings start this month. More information is available here.

The Feb. 4th General Council Meeting will be in-person and live-streamed.

SCHC COVID-19 Information

As of September 1, 2022, Tribal offices began utilizing the Public Access Framework approved by Tribal Council and will remain in effect until there is an approved Tribal Resolution, by Tribal Council.  The Siletz Clinic’s mandate in the Public Access Framework is that we will continue to follow the mask mandate based on Oregon Health Authority and/or other Federal requirements.  Enhanced cleaning protocols will remain in place as long as the mask mandate is in effect for health care facilities. 

Services

Medical/Lab

  • Resume all regular appointment scheduling.

Dental

  • Resume all regular services and scheduling as staffing allows. Siletz Tribal membership scheduling is priority.

Optometry

  • Resume all regular services and scheduling as staffing allows. Siletz Tribal membership scheduling is priority.

    Medication Assistance Therapy (MAT)

    • Face-to-face groups may begin, with social distancing guidelines and group size limits (masks must be worn at all times and participants must pass front door screening).
    • In person 1:1 counseling may resume. Virtual option may remain available according to client need and provider preference.
    • Resume regular UA requirements.

      Pharmacy

      • Resume routine pharmacy services, including opening up pharmacy pick-up window in lobby.
      • Continue expanded mailing service as requested by patient.

        Behavioral Health

            • Resume regular department functions.
            • Face-to-face groups may begin, with social distancing guidelines and group size limits (masks must be worn at all times and participants must pass front door screening).

        Community Health Services

            • Resume regular department functions.
            • Face-to-face groups may begin, with social distancing guidelines and group size limits (masks must be worn at all times and participants must pass front door screening).

        Diabetes/Fitness Center/Community Garden

        Diabetes

        • Resume regular department functions.
        • Face-to-face groups may begin, with social distancing guidelines and group size limits (masks must be worn at all times and participants must pass front door screening).

        Fitness Center

        • Open by appointment during COVID, hours listed on website. The Fitness Center will increase appointment capacity to 3 per hour.
        • Walk-ins will be added to appointment software by staff at the time they walk in as long as there is at least 1 of 3 appointments open.
        • Request workout time limited to 45 minutes to allow staff time to clean prior to next appointment.
        • Guests must wear a properly fitting mask the entire time while in the building including during workout.

        Community Garden

        • Resume normal garden functions.

        Siletz Clinic Covid Resource Line

        Call the Siletz Clinic Covid Resource Line at 541-444-9636541-444-9636

        Covid Home Test Kits and Masks available to those who do not actively have Covid.

        There are additional resources for those who test positive for Covid.

        Services are dependent on availability for Siletz Tribal members, Siletz Clinic patients, and Siletz community members.

        Siletz Area Offices have Covid Home Test Kits and masks available to Siletz members and their families.

        COVID-19 Testing

        COVID-19 testing is available at the Siletz Clinic by appointment. Please call the Front Desk at 541-444-1030. If you are symptomatic, you will be directed to a Clinic Nurse to be Triaged.  If you need a test for travel or an event and are asymptomatic (no symptoms), please let our front desk staff know, they can schedule you an appointment with our lab.

        Symptoms of COVID-19

        • Fever or chills
        • Cough
        • Shortness of breath/difficulty breathing
        • Fatigue
        • Muscle/body aches
        • Headache
        • NEW loss of taste or smell
        • Sore throat
        • Congestion/runny nose
        • Nausea/vomiting
        • Diarrhea

        Emergency Warning Signs* for COVID-19

         If someone shows any of these signs, seek emergency medical care immediately:

        • Trouble breathing
        • Persistent pain/pressure in the chest
        • New confusion
        • Inability to wake or stay awake
        • Pale, gray, or blue-colored skin, lips, or nail beds, depending on skin tone

        *This list is not all possible symptoms. Please call your medical provider for any other symptoms that are sever of concerning.

        The information above was gathered from the CDC.

        What to Do if You Test Positive on a Home Test Kit

        Please call our COVID line at 541-444-9636 and leave the following information: your full name, date of birth, date of positive test, and a phone number where we can reach you. If you are having concerning symptoms or need to talk to someone right away please call 541-444-1030 and ask to speak to nurse for COVID triage.

        More information about quarantine and isolation can be found on the CDC website.

        OHA has created an online resource for individuals who test positive for COVID-19.

        Guidelines for a Positive Test or Close Contact

        As of March 12, 2022, most people exposed to COVID-19 (i.e., close contacts) no longer need to quarantine (i.e., stay away from other people during the time they are most likely to become infected).  However, close contacts should be aware of their potential to become infected and infect others around them.

        Recommendations for the General Population:

        • All confirmed and presumptive cases, including asymptomatic cases, should isolate until they meet criteria for discontinuation of isolation. Cases should stay home and away from other people at least 5 days since their symptom onset, and until 24 hours after fever is gone without use of antipyretics (ibuprofen/Tylenol, aspirin), and other COVID-19 symptoms are improving.
          • Cases should also wear a mask when they are around other people in the 10 days after they become sick or test positive.
          • This includes wearing a well-fitting mask around others at home and in public for 5 additional days (day 6 through day 10) after the end of their 5-day isolation period.
        • Individuals who cannot or do not mask during days 6–10 of their isolation period should stay home for 10 days.
          • Cases should avoid people who are at increased risk for severe disease as well as nursing homes and other high-risk congregate settings for 10 days.
          • If the case is asymptomatic or discrete onset of symptoms cannot be determined, they should stay home for five days following the specimen collection date of their positive test.
          • If an asymptomatic case develops symptoms compatible with COVID-19 (e.g., fever, cough, diarrhea, new loss of taste or smell, or shortness of breath) before the end of their initial isolation period, the five-day isolation and 10-day masking period should be restarted on the date of symptom onset.

        All Close Contacts, Regardless of Vaccination Status or Prior Infection With COVID-19 Are Recommended to:

        • Watch for COVID-19 like symptoms for 10 days after their last exposure.
        • Stay home and get tested if symptoms develop.
        • Wear a well-fitting mask around other people for the 10 days following their last exposure.
        • Avoid unnecessary visits with high-risk individuals (e.g., residents of congregate care facilities, persons with immunocompromising conditions, etc.).
        • Consider testing approximately five days after their exposure.
        • Follow guidance for isolation if they test positive or develop COVID-19 symptoms.

        If a close contact develops any symptoms associated with COVID-19, regardless of vaccination status, they should isolate for 5 days following the onset of their symptom(s).

        COVID-19 Vaccine Information

        The Siletz Clinic continues to offer Covid vaccines every Friday. Specific dates and times are subject to change and will be available to view on our social media pages. We offer Moderna, Pfizer-BioNTech, and Novavax vaccines. You can receive a first dose, second dose, third dose, and bivalent booster dose at our location (availability may vary depending on shipment arrival each week). See COVID Vaccine and Booster Information below for timelines.

        Covid Vaccinations – February 2023 and Beyond

        The Friday Covid Vaccination Clinic is changing; we will offer Covid vaccines by appointment.

        Location to Receive a Covid Vaccine

        Siletz Community Health Clinic at 200 Gwee Shut Road, Siletz, Oregon

        Who Can Receive a Covid Vaccine at the Siletz Clinic?

        Anyone (Tribal members, patients, non-patients, people in or out of our community)

        When Can I Get a Covid Vaccine?

        Monday – Thursday from 8:15 AM – 4:00 PM
        Friday from 10:00 AM – 4:00 PM

        Phone Number to Call to Schedule a Covid Vaccine

        541-444-1030 or 800-648-0449

        If you have any questions, please call the Siletz Clinic Covid Resource Line at 541-444-9636 and we will call you back.

        COVID Vaccine and Booster Information

        Bivalent Boosters

        Updated (Bivalent) Boosters

        The updated (bivalent) boosters are called “bivalent” because they protect against both the original virus that causes COVID-19 and the Omicron variant BA.4 and BA.5.

        Previous boosters are called “monovalent” because they were designed to protect against the original virus that causes COVID-19. They also provide some protection against Omicron, but not as much as the updated (bivalent) boosters.

        The virus that causes COVID-19 has changed over time. The different versions of the virus that have developed over time are called variants. Learn more about variants of the COVID-19 virus.

        Two COVID-19 vaccine manufacturers, Pfizer and Moderna, have developed updated (bivalent) COVID-19 boosters.

        Do Not Mix Primary Series

        CDC does not recommend mixing products for your primary series doses. If you received Pfizer-BioNTech, Moderna, or Novavax for the first dose of your primary series, you should get the same product for all following primary series doses.

        Mixing Boosters

        The following information applies to boosters for people ages 5 and older. Children under age 5 years are not recommended to receive a booster at this time.

        Children Age 5 Years Old

        Children age 5 years old are only currently recommended to receive the updated (bivalent) Pfizer-BioNTech booster, and they can get this booster whether they received the Pfizer-BioNTech or Moderna primary series.

        Children age 5 years old can no longer get an original (monovalent) mRNA (Pfizer-BioNTech or Moderna) booster.

        People Ages 6 Years and Older

        People ages 6 years and older can get a different product for their updated (bivalent) booster than they received for their primary series or last booster. People ages 6 years and older can no longer get an original (monovalent) mRNA (Pfizer-BioNTech or Moderna) booster.

         Vaccine Schedules and Timelines by Manufacturer

        Children and Teens 6 Months to 17 Years

        Pfizer BioNTech

        Age Group: 6 Month – 4 Years

        1st Dose 2nd Dose* 3rd Dose
        Primary Series
        Pfizer BioNTech
        Primary Series
        Pfizer BioNTech
        3-8 weeks after 1st dose
        Primary Series
        Pfizer BioNTech
        At least 8 weeks after 2nd dose

        Up to Date: 2 weeks after 3rd dose, since a booster is not recommended for this age group at this time.

        Age Group: 5 – 11 Years

        1st Dose 2nd Dose* 3rd Dose
        Primary Series
        Pfizer BioNTech
        Primary Series
        Pfizer BioNTech
        3-8 weeks after 1st dose
        Updated (BIVALENT) Booster
        Pfizer BioNTech
        At least 2 months after 2nd dose or last booster, children age 5 years can only get a Pfizer-BioNTech booster, and children ages 6-11 years can get a Pfizer-BioNTech or Moderna Booster.

        Up to Date: Immediately after you have received the most recent booster recommended for you.

        Age Group: 12 – 17 Years

        1st Dose 2nd Dose* 3rd Dose
        Primary Series
        Pfizer BioNTech
        Primary Series
        Pfizer BioNTech
        3-8 weeks after 1st dose
        Updated (BIVALENT) Booster
        Pfizer BioNTech or Moderna
        At least 2 months after 2nd dose or last booster.

        Up to Date: Immediately after you have received the most recent booster recommended for you.

        Moderna

        Age Group: 6 Month – 4 Years

        1st Dose 2nd Dose* 3rd Dose
        Primary Series
        Moderna
        Primary Series
        Moderna
        4-8 weeks after 1st dose
        Children 6 months – 4 years are not recommended for a booster.

        Up to Date: 2 weeks after completing the 2nd dose of their primary series.

        Age Group: 5 Years

        1st Dose 2nd Dose* 3rd Dose
        Primary Series
        Moderna
        Primary Series
        Moderna
        4-8 weeks after 1st dose
        Updated (BIVALENT) Booster
        Pfizer BioNTech Booster ONLY
        At least 2 months after 2nd dose.

        Up to Date: Immediately after you have received the most recent booster recommended for you.

        Age Group: 6 – 17 Years

        1st Dose 2nd Dose* 3rd Dose
        Primary Series
        Moderna
        Primary Series
        Moderna
        4-8 weeks after 1st dose
        Updated (BIVALENT) Booster
        Moderna or Pfizer BioNTech
        At least 2 months after 2nd primary series dose.

        Up to Date: Immediately after you have received the most recent booster recommended for you.

        Novavax

        Age Group: 12 – 17 Years

        1st Dose 2nd Dose* 3rd Dose
        Primary Series
        Novavax
        Primary Series
        Novavax
        3-8 weeks after 1st dose
        Updated (BIVALENT) Booster
        Moderna or Pfizer BioNTech
        At least 2 months after 2nd primary series dose.

        Up to Date: Immediately after you have received the most recent booster recommended for you.

        Adult Ages 18 Years and Older

        Pfizer BioNTech

        Age Group: 18 Years and Older

        1st Dose 2nd Dose* 3rd Dose
        Primary Series
        Pfizer BioNTech
        Primary Series
        Pfizer BioNTech
        3-8 weeks after 1st dose
        Updated (BIVALENT) Booster
        Pfizer BioNTech or Moderna
        At least 2 months after 2nd primary series dose or last booster.

        Up to Date: Immediately after you received the most recent booster recommended for you.

        Moderna

        Age Group: 18 Years and Older

        1st Dose 2nd Dose* 3rd Dose
        Primary Series
        Moderna
        Primary Series
        Moderna
        4-8 weeks after 1st dose
        Updated (BIVALENT) Booster
        Moderna or Pfizer BioNTech 
        At least 2 months after 2nd primary series dose or last booster.

        Up to Date: Immediately after you received the most recent booster recommended for you.

        Novavax

        Age Group: 18 Years and Older

        1st Dose 2nd Dose* 3rd Dose
        Primary Series
        Novavax
        Primary Series
        Novavax
        3-8 weeks after 1st dose
        Updated (BIVALENT) Booster
        Moderna or Pfizer BioNTech 
        At least 2 months after 2nd primary series dose.

        Up to Date: Immediately after you received the most recent booster recommended for you.

        Johnson & Johnson’s Janssen

        Age Group: 18 Years and Older

        1st Dose 2nd Dose
        Primary Series Updated (BIVALENT) Booster
        Moderna or Pfizer BioNTech 
        At least 2 months after 1st dose or last booster.

        Up to Date: Immediately after you received the most recent booster recommended for you.

        SCHC does not offer the J&J/Janssen vaccine.

        COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised

        Immunocompromised Children and Teens 6 Months to 11 Years

        Pfizer BioNTech

        Age Group: 6 Month – 4 Years

        1st Dose 2nd Dose 3rd Dose
        Primary Series
        Pfizer BioNTech
        Primary Series
        Pfizer BioNTech
        3 weeks after 1st dose
        Primary Series
        Pfizer BioNTech
        At least 8 weeks after 2nd dose

        Up to Date: 2 weeks after 3rd dose in primary series, since a booster is not recommended for this age group at this time.

        Age Group: 5 – 11 Years

        1st Dose 2nd Dose 3rd Dose 4th Dose
        Primary Series
        Pfizer BioNTech
        Primary Series
        Pfizer BioNTech
        3 weeks after 1st dose
        Primary Series
        Pfizer BioNTech
        At least 4 weeks after 2nd dose.
        Updated (BIVALENT) Booster
        Pfizer BioNTech or Moderna
        At least 2 months after 3rd.

        Up to Date: Immediately after you have received the most recent booster recommended for you.**

        Moderna

        Age Group: 6 Month – 4 Years

        1st Dose 2nd Dose 3rd Dose 4th Dose
        Primary Series
        Moderna
        Primary Series
        Moderna
        4 weeks after 1st dose
        Primary Series
        Moderna
        At least 4 weeks after 2nd dose
        Children 6 months to 4 years are not recommended for a booster.

        Up to Date: 2 weeks after completing the 3rd dose of their primary series.

        Age Group: 5 Years

        1st Dose 2nd Dose 3rd Dose 4th Dose
        Primary Series
        Moderna
        Primary Series
        Moderna
        4 weeks after 1st dose
        Primary Series
        Moderna
        At least 4 weeks after 2nd dose.
        Updated (BIVALENT) Booster
        Pfizer BioNTech ONLY
        At least 2 months after 3rd dose.

        Up to Date: Immediately after you have received the most recent booster recommended for you.**

        Age Group: 6 – 11 Years

        1st Dose 2nd Dose 3rd Dose 4th Dose
        Primary Series
        Moderna
        Primary Series
        Moderna
        4 weeks after 1st dose
        Primary Series
        Moderna
        At least 4 weeks after 2nd dose.
        Updated (BIVALENT) Booster
        Moderna or Pfizer BioNTech
        At least 2 months after 3rd dose.

        Up to Date: Immediately after you have received the most recent booster recommended for you.**

        Immunocompromised Pre-teens, Teens, and Adults

        Pfizer BioNTech

        Age Group: 12 – 17 Years

        1st Dose 2nd Dose 3rd Dose 4th Dose
        Primary Series
        Pfizer BioNTech
        Primary Series
        Pfizer BioNTech
        3 weeks after 1st dose
        Primary Series
        Pfizer BioNTech
        At least 4 weeks after 2nd dose
        Updated (BIVALENT) Booster
        Pfizer BioNTech or Moderna
        At least 2 months after 3rd dose.

        Up to Date: Immediately after you have received the most recent booster recommended for you.**

        Age Group: 18 Years and Older

        1st Dose 2nd Dose 3rd Dose 4th Dose
        Primary Series
        Pfizer BioNTech
        Primary Series
        Pfizer BioNTech
        3 weeks after 1st dose
        Primary Series
        Pfizer BioNTech
        At least 4 weeks after 2nd dose.
        Updated (BIVALENT) Booster
        Pfizer BioNTech or Moderna
        At least 2 months after 3rd dose or last booster.

        Up to Date: Immediately after you have received the most recent booster recommended for you.**

        Moderna

        Age Group: 12 – 17 Years

        1st Dose 2nd Dose 3rd Dose 4th Dose
        Primary Series
        Moderna
        Primary Series
        Moderna
        4 weeks after 1st dose
        Primary Series
        Moderna
        At least 4 weeks after 2nd dose.
        Updated (BIVALENT) Booster
        Moderna or Pfizer BioNTech
        At least 2 months after 3rd dose or last booster.

        Up to Date: Immediately after you have received the most recent booster recommended for you.**

        Age Group: 18 Years and Older

        1st Dose 2nd Dose 3rd Dose 4th Dose
        Primary Series
        Moderna
        Primary Series
        Moderna
        4 weeks after 1st dose
        Primary Series
        Moderna
        At least 4 weeks after 2nd dose.
        Updated (BIVALENT) Booster
        Moderna or Pfizer BioNTech
        At least 2 months after 3rd dose or last booster.

        Up to Date: Immediately after you have received the most recent booster recommended for you.**

        Novavax

        Age Group: 12 – 17 Years

        1st Dose 2nd Dose 3rd Dose
        Primary Series
        Novavax
        Primary Series
        Novavax
        3 weeks after 1st dose
        Updated (BIVALENT) Booster
        Moderna or Pfizer BioNTech 
        At least 2 months after 2nd primary series dose.

        Up to Date: Immediately after you received the most recent booster recommended for you.**

        Age Group: 18 Years and Older

        1st Dose 2nd Dose 3rd Dose
        Primary Series
        Novavax
        Primary Series
        Novavax
        3 weeks after 1st dose
        Updated (BIVALENT) Booster
        Moderna or Pfizer BioNTech 
        At least 2 months after 2nd primary series dose.

        Up to Date: Immediately after you received the most recent booster recommended for you.**

        Johnson & Johnson’s Janssen

        Age Group: 18 Years and Older

        1st Dose 2nd Dose 3rd Dose
        Primary Series
        J&J/Janssen
        Additional Dose
        At least 4 weeks after 1st dose and should be Pfizer BioNTech or Moderna
        Updated (BIVALENT) Booster
        Moderna or Pfizer BioNTech 
        At least 2 months after 2nd dose or last booster.

        Up to Date: Immediately after you received the most recent booster recommended for you.**

        SCHC does not offer the J&J/Janssen vaccine.

        *Getting your 2nd dose: Talk to your healthcare or vaccine provider about the timing for the 2nd dose in your primary series.

        • People ages 6 months through 64 years, and especially  males ages 12 through 39 years, may consider getting the 2nd primary Pfizer-BioNTech, Moderna, or Novavax 8 weeks after the 1st dose.
          • A longer time between the 1st and 2nd primary doses may increase how much protection the vaccines offer, and further minimize the rare risk of myocarditis and pericarditis.
        • Anyone wanting protection due to high levels of community transmission, people ages 65 years and older, or people who are more likely to get very sick from COVID-19, should get the second dose of:
          • Pfizer-BioNTech COVID-19 vaccine 3 weeks (or 21 days) after the first dose.
          • Moderna  COVID-19 vaccine 4 weeks (or 28 days) after the first dose.
          • Novavax  COVID-19 vaccine 3 weeks (or 21 days) after the first dose.

        **Staying up to date: If you have completed your primary series, but are not yet eligible for a booster, you are also considered up to date.

        Who is Moderately or Severely Immunocompromised?

        People are considered to be moderately or severely immunocompromised (have a weakened immune system) due to several types of conditions and treatments. Examples include:

        • Tumors or cancers of the blood with or without active cancer treatment
        • Received an organ or islet transplant and are taking medicine to suppress the immune system
        • Received chimeric antigen receptor (CAR)-T-cell therapy (a treatment to help your immune system attach to and kill cancer cells) or received a stem cell transplant (within the last 2 years)
        • Moderate or severe primary immunodeficiency (such as common variable immunodeficiency disease, severe combined immunodeficiency, DiGeorge syndrome, Wiskott-Aldrich syndrome)
        • Advanced or untreated HIV infection
        • Active treatment with high-dose corticosteroids or other drugs that may suppress the immune response
        • Talk to your healthcare provider about COVID-19 vaccination and your medical condition

        Information in this area can be found at:
        https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html#up-to-date and
        https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html

        COVID-19 Information Resources

        Keeping Everyone Safe Over the Holiday Season

        Recent events such as the Restoration Pow Wow and upcoming holiday gatherings are opportunities for spread of disease and illness. Here are a few tips to stay healthy and limit spreading disease during holiday gatherings.

        1. Get your flu shot and make sure you are up to date on COVID-19 vaccinations, including the new bivalent booster.
        2. Cover you cough and sneezes with your elbow or tissue.
        3. Wash hands regularly with soap and water or use hand sanitizer.
        4. Clean high-touch surfaces routinely, especially before and after hosting a gathering.
        5. Those who are at high risk of complications from the variety of viruses circulating, should consider wearing a mask when in-doors with people not in their household.
        6. Stay home if you are sick.

        COVID-19 continues to circulate in the community. We are also seeing people test positive for Influenza and RSV (respiratory syncytial virus). RSV is a common respiratory virus that usually causes mild cold-like symptoms, that most children have had by the age of 2 years. Many viruses have symptoms that are same or similar.

        Signs and symptoms in kids COVID-19
        (the new coronavirus)
        Influenza
        (the flu)
        RSV/
        bronchiolitis
        Common
        respiratory infections
        (colds)
        Seasonal allergies
        (hay fever)
        Onset of symptoms Varies; typically gradual Sudden Varies; typically starts mild Varies Typically sudden or ongoing
        New loss of taste or smell
        Sometimes Uncommon Uncommon Uncommon Sometimes
        Fever Sometimes*; typically high fever Very common; typically high fever Common Varies Never
        Tiredness Severely tired Severely tired Common Varies Sometimes
        Cough Very common; typically dry cough Very common; typically dry cough Very common; often a wheezing cough Varies Sometimes
        Headache Common Very common Uncommon Varies Uncommon
        Loss of appetite or, for babies, difficulty feeding Sometimes Common Common Varies Less common
        Muscle and body aches Common Very common Uncommon Common Uncommon
        Sore throat Common Common Sometimes Common Sometimes; typically mild
        Runny nose/nasal congestion Common Common Very common Common Very common
        Nausea or vomiting Sometimes Sometimes Sometimes Less common Uncommon
        Chills Sometimes Very common Uncommon Less common Never
        Diarrhea Sometimes Sometimes Sometimes Varies Never
        Shortness of breath/breathlessness Sometimes Sometimes Very common Uncommon Uncommon
        Wheezing or audible breathing Sometimes Sometimes Very common Sometimes Uncommon

        It can be challenging to identify the cause of symptoms, especially in younger kids. *Less than half of children diagnosed with COVID-19 will have a fever. Even if your child does not have a fever, it is possible that they could have COVID-19.

        We have home test kits for COVID-19. They are available at the SCHC pharmacy or by calling the COVID resource line at 541-444-9636. We have testing available for influenza and RSV at the SCHC. These tests require an office visit with one of our providers. Typically, RSV tests are only done on young kids or elders at high risk for complications. If you are unsure if you or a family member needs to be seen or tested, please call and ask to speak to one of our triage nurses.

        If you or a family member test positive for COVID-19 on a home test, we ask you report those results to our COVID resource line. We have medications that can help reduce the risk of COVID-19 related complications if started within 5 days of symptom onset, please call to speak with a triage nurse, as there are criteria for receiving these medications. If you test positive for influenza there are anti-viral medications that may help reduce severity of disease. Treatment for RSV is symptomatic, such as medications to reduce fever and drinking plenty of fluids to stay hydrated. Please call SCHC at 541-444-1030 if you have questions regarding your symptoms or if you should be evaluated and tested.

        We hope to make your holiday season safe and free from illness, as much as that is possible.

        Centers for Disease Control and Prevention (CDC) Website

        Oregon Health Authority Website

        https://govstatus.egov.com/OR-OHA-COVID-19

        This website has information specific to Oregon including tracking COVID-19, statewide requirements and recommendations, and community resources.  You can also maneuver to other parts of their website for other statewide information.

        Celebrating Health Care (Video)